Quantcast
Last updated on April 23, 2014 at 15:23 EDT

Latest renal failure Stories

2011-10-06 09:13:12

Investigators at the Stanford University School of Medicine have developed a novel protocol that allows kidney-transplant recipients to jettison their indispensable immune-suppressing drugs. The protocol could also spell substantial savings to the health-care system. The researchers have reported their progress in a letter that will be published Oct. 6 in the New England Journal of Medicine. Eight of the 12 patients discussed in the small study have now been off of immunosuppressant drugs...

2011-09-26 08:54:00

LAWRENCE, Mass., Sept. 26, 2011/PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Barry M. Straube, M.D., a member of its Board of Directors, was honored with the Peter Lundin, MD Award from the American Association of Kidney Patients (AAKP) at the organization's 38th Annual Convention in August. The AAKP presents the award yearly to an outstanding renal physician who makes contributions to the care, welfare and...

2011-09-22 07:02:00

NEW YORK, Sept. 22, 2011 /PRNewswire/ -- The American Kidney Fund today launches a national campaign to raise awareness about kidney disease, a serious and increasingly common condition that is damaging the health of as many as 31 million Americans. Pair Up: Join the Fight to Prevent Kidney Disease encourages women to take two simple, yet powerful actions: learn if they're at risk for kidney disease; and spread the word about kidney disease to loved ones who also may be at risk. The launch...

2011-09-21 12:58:22

Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease–a finding that could reverse long-standing clinical practice. Their study appeared in the September 1 online edition of the Journal of Rheumatology. At least 1.5 million Americans (more than 90 percent of them women) have lupus (officially known as lupus...

2011-09-20 13:23:00

BRONX, N.Y., Sept. 20, 2011 /PRNewswire-USNewswire/ -- Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease--a finding that could reverse long-standing clinical practice. Their study appeared in the September 1 online edition of the Journal of Rheumatology. At least 1.5 million Americans (more than 90 percent of...

2011-09-19 15:03:00

Participants met with Members of Congress to Discuss Extending Immunosuppressive Drug Coverage for Transplant Patients, Deficit Reduction Efforts WASHINGTON, Sept. 19, 2011 /PRNewswire-USNewswire/ -- Last week, patient advocates with Dialysis Patient Citizens (DPC) traveled to Washington, D.C. to meet with their Members of Congress and discuss legislative issues important to the 31 million Americans with chronic kidney disease. Participants from 21 states came to the nation's capital for...

2011-09-15 21:05:26

Clinicians can monitor kidney function with a simple equation Equations that estimate a patient's kidney function work as well as direct, invasive measurements, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). This means that many patients with chronic kidney disease (CKD) do not need to undergo the painful and cumbersome procedures that are performed to monitor kidneys' health. Measuring CKD patients' kidney function can help...

2011-09-14 05:30:06

(Ivanhoe Newswire) — High levels of a hormone, FGF-23, can predict which kidney patients will develop heart problems, require dialysis, or die prematurely, according to this study. "This discovery allows us to predict at-risk patients before they require dialysis," lead investigator Michel Chonchol, MD, an associate professor of medicine specializing in nephrology, was quoted as saying. "That's critical because approximately 23 percent of patients on dialysis die in the first year."...

2011-08-26 11:12:46

Treatments could lower kidney failure risk for all African Americans are four times more likely to develop kidney failure than whites. A new study has found that a condition that occurs when the kidneys are damaged and spill protein into the urine contributes to this increased risk. The study, conducted by William McClellan, MD of Emory University and his colleagues, appears in an upcoming issue of the Journal of the American Society Nephrology (JASN), a publication of the American...

2011-08-24 06:40:00

NEWTOWN SQUARE, Pa., Aug. 24, 2011 /PRNewswire/ -- Kibow Biotech, Inc. today announced that it has renewed its exclusive worldwide licensing and marketing agreement with the current licensing partner specializing in animal health. The agreement concerns "Azodyl(TM)," a patented, 100% natural, probiotic dietary supplement indicated for the reduction of azotemia in dogs and cats with moderate to severe renal failure. Developed by Kibow, Azodyl(TM) has been successfully marketed and sold...